French health insurance pioneer Alan has reached a €5 billion ($5.83 billion) valuation after closing a €100 million funding round, defying a market correction that saw 30% of European unicorns lose their billion-dollar status. The capital injection, led by Index Ventures, marks a significant jump from the company’s $4.5 billion valuation in 2024 and signals strong investor confidence in its tech-driven healthcare model.
Strategic Investment and High-Profile Backing
The latest €116 million funding round attracted a diverse group of Tier-1 investors and high-profile business angels. Joining Index Ventures are Greenoaks, Kaaf, and SH, alongside Shopify founder Tobi Lütke and World Cup champion Antoine Griezmann. Belfius, the Belgian banking and insurance leader that spearheaded the previous Series F, also maintained its strategic commitment. This influx of capital supports a workforce of 740 professionals currently serving over one million members across various employment sectors.
Revenue Surges Toward $1 Billion Milestone
Alan reported a massive 53% increase in annual recurring revenue (ARR), reaching €785 million ($915 million) in 2025. This growth trajectory is bolstered by significant contract wins, most notably a landmark agreement to provide health coverage for 135,000 French civil servants and their families. The company has successfully transitioned from serving startups to securing massive private-sector deals with multinational corporations like HP and Volkswagen.
AI Integration and Technological Evolution
CEO Jean-Charles Samuelian-Werve, who also serves as a board member for the French AI powerhouse Mistral AI, confirmed that the new funds will accelerate investments in artificial intelligence. The firm aims to transform its app from a reimbursement tool into a comprehensive health assistant that manages doctor access and tracks wellness habits through proprietary technology. This “tech-first” approach remains the core differentiator as the company scales its digital infrastructure.
Operational Efficiency and Global Expansion Strategy
While the firm prioritizes growth, it has achieved operational profitability in France—the first independent insurer to receive a domestic license since the 1980s. On a global scale, the company is nearing an operating break-even point, having halved its net losses as a percentage of revenue over the last year. Following successful entries into Belgium and Spain, the startup has now secured licenses across all Canadian provinces to begin commercial operations. Management has set a clear target of $1.16 billion in ARR for 2026, opting to prioritize market dominance and product innovation over immediate net profitability.
